AS APF (EGG) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
17 Apr, 2026Executive summary
Achieved record financial performance in FY2025 with revenue reaching €24.3 million, up 92% year-over-year, adjusted EBITDA at €9.2 million (+257%), and net profit at €5.2 million, driven by strategic expansion, new facilities, and product innovation.
Expanded production capacity by 60% through major investments, including new barns and a liquid egg processing plant, and launched new functional nutrition products and packaging formats.
Rebranded and restructured under Agrova International/Baltics, consolidating over 81% of shares, acquiring a top UK egg producer, and expanding the Supervisory Board.
Achieved international certifications (ISO 50001, BRCGS), secured a €5 million bond placement, and signed a market maker agreement to enhance capital markets presence.
Launched new product lines, including Fiteg² nutrition, and expanded into health and sports nutrition, with best-selling SKUs boosting market share and a 24% repeat purchase rate.
Financial highlights
Revenue reached €24.3 million, up 92% year-over-year, with gross profit at €10.8 million (44% margin) and net profit at €5.2 million (21% margin).
Adjusted EBITDA rose 257% to €9.2 million, with EBITDA margin near 40% and EBIT margin at 27.9%.
Return on equity reached 48.1%, and P/E ratio improved to 5.5x.
Earnings per share increased to €0.9 from negative in the prior year.
146 million eggs sold, up 47% year-over-year.
Outlook and guidance
Next investment phase of €30 million planned for 2026–2027, adding three new barns and increasing cage-free capacity.
Targeting 90% cage-free production by 2027 and full transition by 2028.
Focus on premium, branded, and value-added products, direct-to-consumer growth in functional nutrition, and export market expansion.
No specific financial targets for 2026 due to geopolitical uncertainties, but margins expected to remain strong.
Continued investment in production capacity, efficiency, and product portfolio expansion is planned.
Latest events from AS APF
- Cage-free output rose 51% but revenue and profit fell on price pressure and investment costs.EGG
H1 202417 Apr 2026 - Record gross margin and major investments position the business for 60% growth in 2025.EGG
H2 202417 Apr 2026 - Record H1 2025 growth in revenue, EBITDA, and profit, with raised guidance and export strength.EGG
H1 202517 Apr 2026